trial · primary record
TAK-360
Idiopathic Hypersomnia
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2031-06-15 |
| Primary endpoint | Number of Participants With at Least 1 Treatment-Emergent Adverse Event (TEAE) |
| Registry ID | NCT07646678 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:44.176Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07646678
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.